Clinical Trial Update: Loop Diuretic Dosage in Patients With Acute Heart Failure and Renal Failure: Conventional Versus Carbohydrate Antigen 125-guided Therapy (IMPROVE-HF) [Phase 4]

View source ↗

Summary

Phase 4 trial comparing conventional loop diuretic dosing to CA125-guided therapy in patients with acute heart failure and renal failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Snippet

Sponsor: Fundación para la Investigación del Hospital Clínico de Valencia | Conditions: Heart Failure | Phase 4 | Status: COMPLETED